Barbara Klencke - 06 Apr 2023 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Barbara Klencke
Issuer symbol
TCRX
Transactions as of
06 Apr 2023
Transactions value $
$0
Form type
4
Filing time
10 Apr 2023, 10:39:45 UTC
Previous filing
24 Jan 2023
Next filing
15 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Award $0 +9,146 $0 9,146 06 Apr 2023 Voting Common Stock 9,146 $2.2 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in thirty-six equal monthly installments following April 6, 2023, subject to the Reporting Person's continued service at such time.